Synthesis and anticancer activity of chalcone-pyrrolobenzodiazepine conjugates linked via 1,2,3-triazole ring side-armed with alkane spacers

Eur J Med Chem. 2011 Sep;46(9):3820-31. doi: 10.1016/j.ejmech.2011.05.050. Epub 2011 May 30.

Abstract

Aiming to develop multitarget drugs for the anticancer treatment, a new class of chalcone-pyrrolo[2,1-c] [1,4]benzodiazepine (PBD) conjugates linked through a 1,2,3-triazole moiety containing alkane spacers has been designed and synthesized. Combining these two core pharmacophore structures with modifications at A-C8/C-C2-position of PBD ring system yielded analogs with improved efficacy and have shown promising in vitro anticancer activity ranging from <0.1-2.92 μM. These PBD-conjugates caused G1 cell cycle arrest with effect on G1 cell cycle regulatory proteins such as Cyclin D1 and Cdk4. These conjugates also exhibited inhibitory effect on NF-kB, Bcl-XL proteins that play a vital role in breast cancer cell proliferation. These findings suggest that one of the compound 4d among this series is most effective and has potential for detailed investigations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Benzodiazepines / chemistry*
  • Cell Line, Tumor
  • Chalcones / chemistry*
  • Drug Screening Assays, Antitumor
  • Flow Cytometry
  • Humans
  • NF-kappa B / metabolism
  • Pyrroles / chemistry*
  • Triazoles / chemistry*

Substances

  • Antineoplastic Agents
  • Chalcones
  • NF-kappa B
  • Pyrroles
  • Triazoles
  • pyrrolo(2,1-c)(1,4)benzodiazepine
  • Benzodiazepines